Costantini R, Napolitano L, Scurti D, Innocenti P
Istituto di Patologia Chirurgica, Università degli Studi G. D'Annunzio di Chieti.
Ann Ital Chir. 1997 May-Jun;68(3):357-60.
Long-term chemotherapeutic drugs administration in cancer patients requires the use of special devices such as TIS (Totally Implantable Systems) for central venous access without complications such as thrombosis and sepsis. From January 91 to January 95, 42 TIS were implanted in the same number of oncology patients at the Institute of Surgical Pathology of the University of Chieti. The catheters were inserted by surgical incannulation of the cephalic vein in 36 cases, of the external jugular vein in 5 cases and of the internal jugular vein in 1 case. Four complications occurred consisting of 3 cases of haematoma, which were resolved by wound revision and 1 case of port dislocation treated by repositioning without removing the system. It is concluded that TIS are currently the best technological solution in long-term central venous catheterization because of the very low rate of complications and the easier nursing management and significant improvement in the quality of life for these patients.
癌症患者长期使用化疗药物需要使用特殊装置，如全植入式系统（TIS）进行中心静脉通路，以避免血栓形成和败血症等并发症。从1991年1月至1995年1月，基耶蒂大学外科病理学研究所对相同数量的肿瘤患者植入了42个TIS。36例经头静脉手术插管插入导管，5例经颈外静脉插管，1例经颈内静脉插管。发生了4例并发症，包括3例血肿，经伤口修复后解决，1例端口脱位，经重新定位处理，未移除系统。结论是，由于并发症发生率极低、护理管理更容易且这些患者的生活质量有显著改善，TIS目前是长期中心静脉置管的最佳技术解决方案。
